Does opioid substitution treatment have a protective effect on the clinical manifestations of COVID-19? Comment on Br J Anaesth 2020; 125: e382-3

Br J Anaesth. 2021 Mar;126(3):e114-e116. doi: 10.1016/j.bja.2020.11.027. Epub 2020 Nov 28.
No abstract available

Keywords: COVID-19; immunomodulation; inflammation; opioid substitution treatment; opioid use disorder.

Publication types

  • Letter
  • Comment

MeSH terms

  • Analgesics, Opioid
  • COVID-19*
  • Humans
  • Opiate Substitution Treatment
  • Pandemics*
  • SARS-CoV-2

Substances

  • Analgesics, Opioid